Overweight, obesity and eating disorders, such as anorexia nervosa (AN), are complex
conditions, influenced by a variety of factors, including genetic, environmental …

Obesity is a complex pathology that occurs when energy intake exceeds energy expenditure
and is characterized by the accumulation of dysfunctional adipose tissue which triggers …

The incidence of obesity and related metabolic disorders is currently increasing at an
alarming rate in modern society. Therefore, the development of effective antiobesity …

Obesity is a pandemic, gateway disease that has thrived in modern, sedentary, high calorie-
eating societies. Left unchecked, obesity and obesity-related diseases will continue to …

Oleoylethanolamide (OEA) is a lipid amide produced by enterocytes upon the absorption of
dietary fat and participates in the induction of satiety. Through indirect pathways, probably …

Obesity as a multifactorial disorder has been shown a dramatically growing trend recently.
Besides genetic and environmental factors, dysregulation of the endocannabinoid system …

Along with an increase in overweight and obesity among all age groups, the development of
efficacious and safe anti‐obesity strategies for patients, as well as health systems, is critical …

Recently, it has been described the role of fatty acid ethanolamides in the control of feeding
behavior. Oleoylethanolamide (OEA) is a member of this family of lipid mediators regulating …

Oleoyl‐estrone (OE) has been presented as a potential antiobesity therapeutic, but the
published series of studies from one laboratory has not yet been independently confirmed …

Oleoylethanolamide (OEA) is an endogenous lipid that contributes in important ways to the
peripheral regulation of food intake. When administered intraperitoneally, OEA is a potent …